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Abstract 
Obesity is a growing worldwide problem with genetic and environmental causes and an 
underlying basis for many diseases. The aryl hydrocarbon receptor (AHR) is a ligand-activated 
nuclear receptor/transcription factor that is the body’s primary defense to environmental toxicant 
exposures. We used two congenic mouse models that differ at the Ahr gene and which encode 
AHRs with a 10-fold difference in signaling activity. The two Ahr mouse strains were fed a 
Western diet, which differentially affected body size, body fat:body mass ratios, liver size and 
liver metabolism, blood cell profiles, and liver mRNA and miRNA profiles. A low-fat diet had no 
significant differential effects. The results suggest that the AHR plays a large and broad role in 
obesity and associated complications, and importantly, may provide a simple and effective 
therapeutic strategy in the treatment of obesity. 
Introduction 
It is estimated that 25-70% of the underlying basis for obesity is gene based (1, 2) 
making environmental factors a major contributor at 30-75% (3). One of the accepted 
environmental causes for the worldwide rise in obesity and associated problems is the 
increased consumption of the high-calorie, high-fat, low-fiber Western diet. A biological entity 
that tightly links genes and the environment is a nuclear receptor best known for its role in 
xenobiotic metabolism. The aryl hydrocarbon receptor (AHR) is a ligand-activated nuclear 
receptor/transcription factor that regulates genes involved in toxicant metabolism and is the 
body’s primary defense to environmental exposures. AHR signaling is also involved in a number 
of essential non-xenobiotic biological and developmental pathways (4). Upon ligand binding, the 
AHR translocates to the nucleus where it complexes with the AHR nuclear translocator (ARNT). 
The AHR/ARNT heterodimer regulates the transcription of genes in the cytochrome P450 Cyp1 
family, some Phase II detoxification genes, as well as thousands of other genes involved in all 
aspects of cell physiology (5). The AHR is also activated by dietary components, e.g., fats and 
fat derivatives (6); and there is evidence linking the activated AHR to major diseases including 
obesity (7). 
To identify a possible role for the AHR in obesity, we used two mouse models that differ 
at the Ahr gene (Fig. 1A). The two strains were C57Bl/6 (B6 strain), which naturally bears the 
high-affinity AHR encoded by the Ahrb1 allele and the congenic C57Bl/6.D2 (B6.D2 strain) 
bearing the low-affinity AHR encoded by the Ahrd allele naturally found in the DBA/2 mouse 
strain. The two Ahr alleles encode AHRs that differ by approximately 10-fold in ligand binding 
affinities, and in turn, gene induction and gene expression levels, including that of the Cyp1a1 
and Cyp1b1 xenobiotic genes (8). A distinct advantage of using the B6 and B6.D2 mouse 
models is that by virtue of the integral role the AHR plays in response to endogenous and 
environmental agents, any corresponding differences observed in disease states, gene 
expression profiles, and affected signaling pathways are due to the differing capacities of the 
corresponding AHRs. We tested the hypothesis that differential AHR signaling activity causes 
differential effects on body mass, fat metabolism, liver gene expression, and liver physiology. 
Using the B6 and B6.D2 mouse models, we found that the differential AHR signaling activated 
by a Western diet drastically affected body size, blood cell profiles, liver gene expression, and 
liver physiology. 
Results 
There have been hints that the AHR may be a participant in the regulation of fat 
metabolism and obesity. For instance, mice exposed to lower levels of polychlorinated biphenyl­
77 (PCB-77) or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted in increased adipocyte 
2

differentiation, Pparγ expression, and obesity levels; whereas, higher levels of PCB-77 or TCDD 
inhibited adipocyte differentiation and Pparγ expression (9). The intent of the work reported here 
was to test more directly the role of the AHR in obesity and fat metabolism but in lieu of 
exogenous toxicants. Although several studies have examined the relationship between the 
AHR and fat metabolism using a model system comparing functional AHR signaling to one that 
is AHR deficient, none have examined the consequences resulting from different levels of AHR 
signaling activity. 
Differential AHR signaling and obesity. We used two congenic mouse models (Fig. 
1A) that encode AHRs that differ by 10-fold in signaling activity (10). Male mice from B6 and 
B6.D2 mouse strains were placed into two diet groups (n = 8 per group) and fed low-fat regular 
chow (18% of kcal from fat) or Western chow, i.e., (42% of kcal from fat) for 27 weeks beginning 
at 5 weeks of age. By 17 weeks on Western chow, B6 male had significantly greater body mass 
than did the B6.D2 male mice (Fig. 1B), and at the 27-week conclusion, B6 mice on Western 
diet were 16% larger than their B6.D2 counterparts (Table S3). Table S4 displays the average 
mass of the eight mice in each group over the 27-week span. Except for weeks 20 and 21, 
when some of the mice were placed in metabolic cages, the low-fat regular diet had no 
differential effect on the two mouse strains. 
In order to determine whether the significant differences in body mass observed 
between the two mouse strains fed the Western diet were due to metabolic rather than 
differences in behavioral eating habits, three of the eight mice in the low-fat and Western diet 
experimental groups at week 20 in the diet regimen were placed in individual metabolic cages to 
measure food and water intake and urine and feces production. The results presented in Fig. 
1C show that although there were significant differences in the amount of Western vs. regular 
chow consumed and of feces generated, there were no significant differences between mouse 
strains in any of the measured parameters, thus, the difference in body mass between the B6 
and B6.D2 were not due to differences in eating and excretion behavior. 
The increased body mass seen in the B6 mice relative to B6.D2 mice could be due to an 
overall proportional increase in body size rather than an increased relative accumulation of body 
fat. The gonadal fat pad mass to body mass ratio highly correlates to that of the overall body 
white fat to body mass ratio (11). Relative fat mass to body mass between the two strains was 
determined by weighing gonadal fad pad masses at the time of sacrifice. Based on the gonadal 
fat pad mass/body mass ratio, B6 mice relative to B6.D2 mice had a significantly greater white 
fat mass (Fig. 1D); and B6 mice on Western diet to those on regular diet had a significantly 
greater white fat mass to body mass ratio while B6.D2 mice remained statistically unchanged 
(Fig. 1E). Together, these data and the above results suggest that there is an AHR-dependent 
metabolic basis for the significant increase in fat and body masses observed in the B6 vs. 
B6.D2 mice fed a Western diet and not due to a difference in eating habits or to a proportional 
difference in overall body size. 
Liver size and metabolism in B6 vs. B6.D2 mice fed a Western diet. The liver is the 
primary site of dietary fat metabolism and regulator of fat levels in the blood. Several striking 
results led us to conclude that differential AHR activity had a large impact on liver growth and 
metabolism (Table S5). For both mouse strains, the Western chow not only had a major impact 
on body mass after the 27-week diet regimen (Fig. 2A) but also on liver mass (Fig. 2B), in that 
the Western diets caused an approximate two-fold increase in liver mass relative to body mass 
compared to mice of both strains fed regular chow (Fig. 2C). However, the impact of the 
Western diet on liver size was greater for B6 mice to that of B6.D2 mice, in that B6 mice had 
significantly larger livers and liver mass to body mass ratios than did the B6.D2 mice.  
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The hepatomegaly observed in the mice fed the Western diets was reminiscent of non­
alcoholic fatty liver disease, which is most often caused by the accumulation of fat in the liver in 
obese individuals (12). We investigated whether there was differential fat accumulation in mice 
fed Western vs. regular chow and whether there were genotypic differences in fat accumulation 
between strains for each diet. Liver sections were stained with hematoxylin and counter stained 
with eosin, which can reveal the presence of fat storage vesicles. There were no apparent fat 
vesicles in B6 and B6.D2 mice fed regular diet (Fig. 2D,E) and no significant difference in fat 
vesicle volume (Fig. 2H). However, B6 mice fed a Western diet had a significantly greater 
volume of fat storage vesicles than did the B6.D2 strain (p-value = 1.54x10-8) (Fig. 2F-H). 
Alanine aminotransferase (ALT) levels rise dramatically in acute liver damage; whereas, 
aspartate aminotransferase (AST) plasma levels is an indicator of extrahepatic tissue damage. 
B6 mice had significantly greater plasma levels of both AST and ALT compared to that of B6.D2 
mice when both strains were fed the Western diet (Fig. 2I,J). B6 mice also had a lower 
AST/ALT ratio indicating relatively more severe liver damage than in B6.D2 (Fig. 2K). The B6 
mice on the Western diet also presented significantly elevated plasma levels of alkaline 
phosphatase, total protein, and total cholesterol relative to B6.D2 mice (Fig. 2L-N). An 
increased level of alkaline phosphatase (ALP) (Fig. 2L) is another measure of a number of liver 
anomalies, including obesity (13). Increased total protein levels (Fig. 2M) can be associated 
with liver disease but often remain in the normal range (4.6-6.9 g/dl) typically due to a decrease 
in plasma albumin concentration and a concomitant increase of plasma globulin levels, including 
ALT, AST, and ALP. However, there were no significant differences in plasma albumin levels 
between B6 and B6.D2 mice, and we surmised that the above normal total proteins levels 
observed in B6 mice was due primarily to the increased globulin levels. Raised plasma levels of 
total cholesterol (Fig. 2N) is associated with the chronic consumption of fatty diets (14).  
Blood cell numbers are dependent on Ahr genotype and diet. AHR signaling activity 
is required for normal maintenance of hematopoietic stem cell quiescence (15). The AHR acts 
as a negative regulator of hematopoiesis, and changes in AHR signaling induced by exogenous 
toxicants are known to affect stem cell/progenitor cell regulation. Obesity in humans also has a 
large effect on red blood cell (RBC), white blood cell (WBC), and platelet numbers and/or 
activity (16-18), hence, we asked whether the Western diets affected blood cell counts and 
parameters as a result of differential AHR signaling. Blood samples were taken at sacrifice from 
the B6 and B6.D2 mice at the completion of the 28-week diet regimen, and blood cell counts 
were determined from blood smears (Fig. 3 and Table S6). The most notable changes were (i) 
the significant drop in RBC numbers in B6.D2 mice fed Western diet, (ii) the significant increase 
in WBC numbers in both strains fed Western diet, (iii) the significant jump in neutrophil numbers 
in both strains fed Western diet but more so in B6 mice, (iv) the more than doubling of monocyte 
cell numbers for B6.D2 mice fed Western diet, and (v) the platelet numbers for B6.D2 mice were 
far outside the normal range (19) independent of diet and were significantly greater relative to 
that of B6 mice. 
Liver mRNA profiles of B6 and B6.D2 mice fed Western diet vs. regular diet. The 
mRNA levels from liver of B6 and B6.D2 mice fed Western diet were compared to mice of the 
same strain fed regular diet, i.e., the effect of diet on a given Ahr genotype. All differentially 
expressed genes (p-value ≤0.05), for both comparisons (B6W vs. B6R and B6.D2W vs. 
B6.D2R) are displayed in Table S7. The salient observations from the comparisons were the 
following. One, the affected genes (Table S8) and associated biological pathways (Table S9) in 
B6 and B6.D2 mice fed a Western diet were involved primarily in inflammation, immune 
response, sterol and cholesterol metabolism, and lipid metabolism but at generally lower 
differential levels in B6.D2 mice to that of B6 mice. Two, there was a relatively high number of 
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shared genes between B6 and B6.D2 mice in response to a Western diet (Table S8), and not 
surprisingly, the associated biological pathways were involved primarily in inflammation, 
immune response, sterol and cholesterol metabolism, and lipid metabolism (Table S9). Of the 
5,586 total differentially expressed genes between the B6W/B6R and B6.D2W/D2R 
comparisons, 1945 genes (34.8%) were shared, of which 1927 (34.5%) were similarly 
expressed and only 18 (0.3%) were expressed in opposite directions (Fig. 4A). Three, a 
considerable percentage of the total number of differentially expressed genes by B6 (886 
genes, 15.9%) and B6.D2 (2755 genes, 49.3%) mice were unique to that strain (Fig. 4A, Table 
S8). 
The mRNA levels of some genes known to be involved in obesity, lipid and sterol 
metabolism, inflammation, and blood cell development (Table S8), many of which contained 
AHR promoter response elements (REs) (20), were impacted by Western diet in B6 and B6.D2, 
respectively, such as ApoA4 (↑15.9-fold, ↑10.2-fold), which is involved in innate immunity and 
fat localization (21); Anxa2 (↑10.1-fold, ↑10.8-fold; 6 AHR REs), which has a role in 
hematopoietic stem cell homing (22); and Hsd3b5 (↓0.03-fold, ↓0.03-fold), a gene associated 
with hepatic steatosis (23) and which dropped over 30-fold in both strains. Some potentially key 
genes uniquely differentially expressed in the B6W/B6R group of mice (Fig. 4B) included 
metallothionein (Mt1) (↑4.17-fold), a leptin-regulated gene that responds to endoplasmic 
reticulum (ER) stress brought on by obesity (24) and multiple mRNA forms of Insig1 (↓0.40 and 
0.37-fold; 12 AHR REs). INSIG1 is a key regulator in cholesterol metabolism (25), and in 
addition to the AHR, the Insig1 gene is regulated by multiple nuclear receptors including PPARα 
(15 AHR REs), CAR (2 AHR REs), and PXR. Some uniquely differentially expressed genes in 
the B6.D2W/B6.D2R group of mice (Fig. 4C) included Hamp2 (↑9.1-fold), which has role in iron 
metabolism and SMAD phosphorylation (26); and Creld2 (↓0.3-fold), an ER-stress induced gene 
(27). Cellular pathways expressed uniquely in B6 mice fed a Western diet relative to those fed a 
regular diet were associated with inflammation; whereas, genes and pathways unique to B6.D2 
mice dealt more with cellular housekeeping chores, including, protein localization and DNA 
repair (Fig. 4D and E, Tables S8 and S9). 
Liver mRNA profiles of B6 vs. B6.D2 mice fed a regular and Western diet. Whereas 
above, we wanted to determine the effect of diet on each of the Ahr genotypes, here, we wanted 
to determine the effect of Ahr genotype for each diet. Differential gene expression levels (p­
value ≤ 0.05) of B6 and B6.D2 mice fed regular diet were compared to each other and B6 and 
B6.D2 mice fed Western diet were compared to each other (Fig. 4F, Tables S10 and S11). 
Several observations were made from the comparisons. One, there were relatively few shared 
genes between those differentially expressed in B6 vs. B6.D2 mice on regular diet and those 
differentially expressed in B6 vs. B6.D2 mice on Western diet (Table S12). Of the total 1,876 
differentially expressed genes only 73 (3.9%) were shared, of which 48 (2.6%) were similarly 
expressed and 25 (1.3%) were expressed in opposite directions. Two, there were 712 (38.0%) 
unique differentially expressed genes in B6 and B6.D2 mice fed regular chow, from which only 
two statistically significant biological pathways were generated (regulation of nucleobase, 
nucleoside, nucleotide, and nucleic acid transport and response to wounding) (Table S13). 
Three, there were 1091 unique genes differentially expressed in B6 vs. B6.D2 mice fed Western 
chow (Table S12). Thus, the AHR has a huge but distinct impact on gene expression in the liver 
of B6 and B6.D2 mice that is dependent on fat levels in the diet. The gene lists for all four 
comparisons are summarized in Table S14. 
A potentially key differentially expressed gene shared between B6 and B6.D2 fed either 
the Western or regular diets, respectively, (Table S14) was Erdr1 (↑2.4-fold, ↑1.6-fold)), a gene 
involved in hematopoietic stem cell regulation (28). Some potentially important genes expressed 
5

uniquely in the B6W/B6.D2W comparison, in which some contained AHR REs (Fig. 4G) 
included Cyp2d26, Gadd45g, Bhmt, Sqle, and again, the Insig1 (↓0.46-fold; 12 AHR REs) gene. 
Cyp2d26 (↑42-fold; 2 AHR REs) is a candidate gene for the regulation of triglyceride levels (29); 
Gadd45g  (↑2.50-fold; 12 AHR REs) encodes a protein that functions in T cell production (30); 
the Bhmt (↑2.09-fold; 7 AHR REs) gene product is associated with liver steatosis and injury and 
protects hepatocytes from ER stress and excess lipid accumulation (31); and the obesity-
associated Sqle  (↓0.52-fold; 8 AHR REs) gene encodes a protein that carries out a step in 
cholesterol biosynthesis (32). Genes relevant to obesity expressed uniquely in the B6R/B6.D2R 
comparison included Ppp1r3c, Elovl3, and again, the Mt1 (↓0.25-fold) gene. The Ppp1r3c (↑2.3­
fold) gene product is involved in glycogen storage in adipocytes (33); and loss of the Elovl3 
(↑2.2-fold) gene in mice causes reduced adiponectin levels, inhibition of adipose tissue 
expansion, and resistance to diet-induced obesity (34). The major biological pathways affected 
in B6 vs. B6.D2 mice fed Western chow were involved in fat metabolism and synthesis, 
vasculature, and sterol metabolism (Fig. 4H, Table S13). 
miRNA profiles of liver. Studies have shown an important role for miRNAs in fat 
metabolism (35). All statistically significant (p-value ≤0.05) differentially expressed miRNA levels 
from B6 and B6.D2 mice fed Western and regular diets are listed in Tables S15-S19. Those 
differentially expressed miRNAs with a fold-change of two or greater and those with roles known 
to be associated with obesity, non-alcoholic fatty liver disease, and adipogenesis, e.g., mmu­
miR-130b and mmu-miR-132 are shown in Table S19B. However, the majority of the highly 
differentially expressed miRNAs presented in Table S19B have not been described previously 
as playing a role in obesity and deserve further scrutiny. 
Discussion 
AHR signaling and human obesity. There are four well-characterized Ahr allelic 
variants in mice, of which, there is a 10-fold difference in the affinity for the AHR ligand between 
the most responsive/most sensitive allele (Ahrb1 of the B6 mouse) and the least responsive/least 
sensitive allele (Ahrd of the B6.D2 mouse) (36-38). The 10-fold difference in 
affinity/response/sensitivity corresponds to a 10-fold difference in AHR activity. The difference in 
affinity is primarily due to the replacement of an alanine at position 375 (high affinity Ahrb1) with 
a valine (low affinity Ahrd) (39). The results from the mouse model studies should be translatable 
to humans because the affinity and responsiveness of the mouse Ahrd gene is similar to that of 
the human Ahr gene, in which the human AHR has a valine at the equivalent position of 375 in 
the mouse AHR (40). In humans, epidemiological studies have shown an association between 
various polymorphic forms of the AHR and cancer (41) but none to obesity. However, large 
scale human epidemiological studies examining the AHR and obesity have not been conducted. 
Nonetheless, experimental work in mice has revealed a possible link between AHR 
signaling and obesity and fat metabolism. AHR signaling inhibits lipid synthesis, regulates 
adipocyte differentiation, and the loss of AHR activity causes an increase in triglyceride 
synthesis (42). Constitutive AHR signaling in mice caused an increase in the levels and activity 
of fatty acid transport proteins and CD36 (a cell surface fatty acid receptor and translocase and 
of which the Cd36 gene is a transcriptional target of the AHR) inhibition of fatty acid oxidation, 
an increase in peripheral fat mobilization, and hepatic steatosis (43). 
AHR signaling and blood cell numbers. The bone marrow of mice is known to be 
differentially sensitive to differential toxicant-activated AHR signaling (44). Mouse strains 
exposed to benzo[a]pyrene  carrying the low-affinity Ahrd gene, including B6.D2 mice (45), are 
much more sickly and prone to dying than are B6 mice carrying the high-affinity Ahrb1 gene. Fat­
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derived ligands can activate AHR signaling (6), and it may be that fat-derived molecules from 
the Western diet are differentially activating AHR signaling during hematopoiesis to disrupt 
various aspects of blood cell differentiation. As with environmental toxicants, Western diet 
appeared to be generally more detrimental to the blood cells of B6.D2 than to that of B6 mice. 
For example, B6.D2 mice had much higher levels of monocytes than did B6 mice, and obesity is 
associated with low grade chronic inflammation that is derived in part from adipose tissue that 
has been infiltrated with bone marrow-derived, circulating macrophages and monocytes (46). 
Furthermore, the accumulation of macrophages and monocytes in adipose tissue is strongly 
correlated with higher total body fat and body mass index (46).  
The AHR, other nuclear receptors, and obesity. Understanding the regulatory 
pathways that govern fat synthesis, accumulation, and catabolism are key to understanding 
obesity, and nuclear receptors are critical sensors and regulators of fat metabolism. The various 
nuclear receptors involved in fat metabolism participate in extensive cross-regulatory and cross-
signaling interactions among each other and with the AHR We found that the gene expression 
levels of numerous genes encoding nuclear receptors are differentially affected by diet in B6 
and B6.D2 mice and that many of the promoters in genes encoding nuclear receptors possess 
AHR REs (Table S20). 
Probably the most important are the peroxisome proliferator-activated receptors 
(PPARs), which are stimulated by fatty acid derivatives that act as ligands to promote lipid 
synthesis and storage in adipocytes (PPARγ, 1 AHR RE, ↑1.61 in B6W/B6R) and to activate 
oxidation pathways in the liver (PPARα, 15 AHR REs, ↓0.66 in B6W/B6.D2W) and in muscle 
and brown adipocytes (PPARδ) (47). Other important nuclear receptors include retinoic acid 
receptors α and β (RARα and RARβ, ↓0.82 in B6W/B6.D2W; ↑1.43 in B6.D2W/B6.D2R), which 
are activated by retinoic acid (RA) to suppress obesity. RA also serves as a ligand for PPARβ/γ 
to induce genes involved in the regulation of energy homeostasis and insulin responses (48). 
The liver X receptors (LXR, 5 AHR REs) sense oxysterols and regulate genes that decrease 
cholesterol levels and stimulate fatty acid and triglyceride synthesis (↓0.85 in B6W/B6R) (49). 
Although the closely related nuclear receptors constitutive androstane/active receptor (CAR, 2 
AHR REs) and pregnane X receptor (PXR) are known primarily for xenobiotic metabolism (50), 
activation of CAR significantly reduces serum glucose levels, improves glucose tolerance and 
insulin sensitivity, and inhibits the expression of lipogenic genes of the liver in mice fed a 
Western diet (51). On the other hand, the activated PXR induces lipogenesis and suppresses 
several genes involved in fatty acid oxidation (↑1.22 in B6W/B6R) (52). Members of the retinoid 
X receptor family (RXRα with 10 AHR REs, RXRβ, and RXRγ with 7 AHR REs), which can form 
homodimers as well as serve as the heterodimeric binding partners for the PPARs, RARs, 
LXRs, CARs, and PXRs (53), bind diet-derived lipophilic ligands, and in turn, modulate lipid 
homeostasis (54). The AHR is also activated by fat derivatives, including eicosanoids and low-
density lipoproteins (6, 55), and thus, the observed body size differences between B6 and 
B6.D2 mice may be due to direct differential activation of AHR signaling via fats. 
The AHR as a therapeutic approach to obesity. In summary, we have shown that 
mice with the high-affinity AHR are more susceptible to obesity than mice with the low-affinity 
AHR when fed Western diet. The broad binding specificity of the AHR for different ligands 
suggests the potential for simple preventative and therapeutic strategies, and if AHR signaling 
activities of similar diversity are found in the human population, then the AHR could serve as a 
means to combat obesity. The demonstration that obesity may be dependent on AHR signaling 
may allow easy manipulation via dietary compounds that act as AHR antagonists such as 
curcumin (56, 57) and resveratrol (58); and commercially available drugs that act as powerful 
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AHR antagonists, including CH-223191 (59, 60) and 6,2,4-trimethoxyflavone (61). The 
regulation of AHR levels and activity by siRNA approaches (62) could also prove promising. 
Methods 
Mice. The mouse strains are available and maintained at The Jackson Laboratory (Bar 
Harbor, ME; Strain names: C57BL/6J and B6.D2N-Ahrd/J; Stock numbers:  000664 and 
002921, respectively). The C57BL/6 mouse possesses the high-affinity AHR (Ahrb1 allele, B6 
strain) and the congenic C57BL/6.D2 mouse strain harbors the low-affinity AHR (Ahrd allele, 
B6.D2 strain) (Fig. 1). 
Histology. Sections (~5-μm thickness) from formalin-fixed, paraffin-embedded liver 
samples were stained with hematoxylin and eosin. The histology procedures were carried out by 
the Pathology Shared Resource at Dartmouth Hitchcock Medical Center. 
Plasma chemistry. The plasma chemistry analyses were carried out by the 
Serology/Clinical Pathology Division of Charles River Laboratory (Wilmington, MA). 
Microarrays.  The mRNA and miRNA gene expression microarray experiments were 
carried out by the Dartmouth Genomics & Microarray Laboratory (DGML) using the MouseRef-8 
v2.0 Expression BeadChip array (Illumina, San Diego, CA) and Affymetrix GeneChip miRNA 2.0 
Array (Affymetrix, Santa Clara, CA), respectively. Four biological replicates per experimental 
condition were carried out. An intensity-based, modified t-test (63) was used to characterize the 
significance level of each feature using limma R packages from Bioconductor (64). Experiments 
are described in greater detail in SI Methods. 
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Figure Legends
Fig. 1. B6 mice become more obese than B6.D2 mice on Western diets. The B6 and B6.D2 
mouse strains possess the high- and low-affinity Ahr genes, respectively, of which there is a 10­
fold difference between the most responsive/most sensitive allele (Ahrb1) and the least 
responsive/least sensitive allele (Ahrd) (A). The B6 and B6.D2 male mice (n = 8 
mice/experimental group) were fed low-fat regular chow (Reg) or a Western diet (West) for 27 
weeks (B). Consumption and excretion amounts of B6 and B6.D2 male mice on regular vs. 
Western diets (C). B6 male mice accumulate significantly more fat mass than B6.D2 male mice 
on Western diet (D). Gonadal fat pads were extracted and weighed from the B6 and B6.D2 male 
mice fed low-fat regular diet or Western diet in order to determine differential white fat 
accumulation: ratio = gonadal fat pad mass (g) / body mass (g) (E). Error bars represent 
Standard Error of the Mean (SEM). 
Fig. 2. B6 mice fed Western diets develop significantly larger, more steatotic, and more severely 
damaged livers than do B6.D2 mice. B6 and B6.D2 male mice (n = 8 mice/experimental group) 
were fed low-fat regular chow or a Western diet for 27 weeks. At sacrifice, body mass (A), liver 
mass (B), and body mass:liver mass ratios (C) were determined. The collected livers were 
formalin fixed, sectioned in paraffin, stained with hematoxylin and eosin, and viewed at 200X 
magnification for B6 mouse fed regular diet (D), B6.D2 mouse fed regular diet (E), B6 mouse 
fed Western diet (F), and B6.D2 mouse fed Western diet (G). The mean total vacuole area per 
10 fields of vision for four mice from each experimental group is plotted (H). Plasma levels of 
alanine aminotransferase or ALT (I), aspartate aminotransferase or AST (J), AST/ALT ratios 
(K), alkaline phosphatase (L), total protein (M), and total cholesterol (N) were determined. Error 
bars represent SEM. 
Fig. 3. Blood cell counts. Blood samples were obtained at sacrifice from B6 and B6.D2 mice 
regular vs. Western diet (A). Blood cell counts were taken from blood smears (n = 
8/experimental group) (B). Error bars represent SEM. 
Fig. 4. The most changed RNA levels of genes and corresponding inferred biological pathways 
of the liver from B6 vs. B6.D2 mice fed regular (R) vs. Western (W) diets. Four mice were 
selected from each experimental group for microarray analysis. Venn diagrams display the 
number of differentially expressed genes from the effect of diet on Ahr genotype (A) and the 
effect of Ahr genotype on diet (F). The twenty genes with the greatest change in differential 
mRNA expression (p-value ≤0.05) that were exclusively expressed in B6W vs. B6R (B), 
B6.D2W vs. B6.D2R (C), and B6W vs. B6.D2W (G) are listed. Genes with cognate AHR 
promoter response elements (REs) are shaded in gray. The differentially expressed genes were 
annotated with functional assignments using the Gene Ontology (GO) biological process-FAT 
database to determine which gene categories were enriched (FDR ≤1.0) for B6W vs. B6R (D), 
B6.D2W vs. B6.D2R (E), and B6W vs. B6.D2W (H). 
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A F 
Genes Unique 
B6W / B6R 
B Genes Unique to 
B6.D2W / B6.D2R 
C Genes Unique 
B6W / B6.D2W 
G 
Number 
AHR REs 
Gene       Fold 
Name       Change 
Number 
AHR REs 
Gene                Fold 
Name Change 
Number 
AHR REs 
Gene Fold 
Name  Change 
Mt1 4.17 0 
C1qb 3.03 5 
H2-Ab1 2.78 0 
Tnfrsf12a 2.63 10 
Chac1 2.63 0 
Saa1 2.56 0 
C1qc 2.38 0 
Hspb1 2.33 0 
Plk3 2.27 9 
Lgmn 2.22 2 
Hamp2 9.09 0 
Spon2 3.33 3 
8430408G22Rik 3.13 4 
Lip1 2.94 2 
4930572J05Rik 2.94 0 
Gsta2 2.86 0 
Gstm2 2.86 3 
Lbh 2.78 0 
Gstm2 2.70 3 
Srebf1 2.63 7 
Cyp2d26 42.02 2 
Gadd45g 2.50 12 
Bhmt 2.09 7 
Gadd45g 2.05 12 
Bax 1.83 0 
Gpd1 1.75 7 
Clec4f 1.72 0 
Bst2 1.69 0 
Hmox1 1.60 4 
Ccl4 1.57 4 
Ctsa 0.51 0 
Slc38a4 0.51 2 
Insig1 0.51 12 
Sc5d 0.48 5 
Aldoc 0.47 0 
LOC100040592 0.46 0 
Ppp1r3c 0.43 0 
Sucnr1 0.42 0 
Insig1 0.40 12 
Insig1 0.37 12 
Hsp105 0.44 8 
Scara5 0.43 0 
G6pc 0.42 6 
Lpin1 0.40 12 
Hamp 0.40 2 
Ccbl2 0.34 0 
Acot1 0.33 0 
Eif4ebp3 0.29 0 
Creld2 0.28 0 
Creld2 0.27 0 
Cyp17a1 0.59 3 
Gnat1 0.59 0 
Gpam 0.58 4 
Sc4mol 0.58 6 
Pcsk9 0.57 6 
Spp1 0.56 3 
Sqle 0.52 8 
Esm1 0.50 0 
Insig1 0.50 12 
Insig1 0.46 12 
Pathways Unique to B6W / B6R D Pathways Unique to B6W / B6.D2W H 
GO:0002026~regulation of the force of heart contraction 
GO:0006954~inflammatory response 
GO:0009611~response to wounding 
GO:0055114~oxidation reduction 
GO:0051186~cofactor metabolic process 
GO:0033554~cellular response to stress 
GO:0008610~lipid biosynthetic process 
GO:0006732~coenzyme metabolic process 
GO:0008202~steroid metabolic process 
GO:0001568~blood vessel development 
GO:0006974~response to DNA damage stimulus 
GO:0001944~vasculature development 
E Pathways Unique to B6.D2W / B6.D2R 
GO:0046907~intracellular transport 
GO:0045184~establishment of protein localization 
GO:0015031~protein transport 
GO:0033554~cellular response to stress 
GO:0008104~protein localization 
GO:0006974~response to DNA damage stimulus 
GO:0009057~macromolecule catabolic process 
GO:0044265~cellular macromolecule catabolic process 
GO:0034613~cellular protein localization 
GO:0006259~DNA metabolic process 
GO:0070727~cellular macromolecule localization 
GO:0030163~protein catabolic process 
GO:0006886~intracellular protein transport 
GO:0006281~DNA repair 
GO:0051186~cofactor metabolic process 
GO:0006396~RNA processing 
GO:0055114~oxidation reduction 
GO:0044257~cellular protein catabolic process 
GO:0051603~proteolysis in cellular protein catabolism 
GO:0006888~ER to Golgi vesicle-mediated transport 
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